Following a heart transplant, patients must undergo surgical biopsies so that clinicians can monitor for signs of organ rejection. A new study shows the promise of a biomarker that could allow doctors ...

InterShunt Technologies announced today that it began an early feasibility study of its device for reducing heart failure symptoms.

Heart attacks are no longer the leading cause of heart disease-related death, but deaths from heart disease have still been ...

These are called Holter monitors and they are essentially ambulatory ECG devices that monitor the heart. Such monitors can ...

Heart attack is one of the most rampant conditions in the world, which is escalating because of a failure to understand the ...

Patients were screened from both a single cardiologist practice and a specialty heart failure (HF) clinic and were included ... making both interventions viable and better than treatment as usual. Our ...

“Thankfully, we’ve made progress in better identifying patients and administering treatment quickly, so they’re living longer, but they then develop the secondary consequence of progressive heart ...